Designing at-source and end-of-pipe biotechnologies to tackle pharmaceutical pollution.

Pharmaceutical pollution, defined as the presence of antibiotics, antidepressants, antidiabetics, and other pharmaceuticals in the environment, is a ubiquitous problem. Active pharmaceutical ingredients (APIs), along with their metabolites and excipi…

Preview only. Read the full abstract at the source